Skip to content
Recall Observatory FDA recall evidence

Drug product

Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.14 mg per day, 50/140 Twice Weekly, Rx Only a) 2 Systems NDC 68968-0514-2 b) 8 Systems NDC 68968-0514-8, Mfd. by: Noven Pharmaceuticals, Inc., Miami, Florida 33186, Dist. by: Noven Therapeutics LLC, Miami, Florida 33186

D-0724-2021

July 30, 2021

Class II

Product summary

Firm
Noven Pharmaceuticals Inc
Event
Event 88342
Status
Ongoing
Classification
Class II
Quantity
223,382 boxes
Official record key
drug-enforcement:D-0724-2021

Official wording

Reason: Failed Stability Specifications; out of specification for shear.

Code information: Lots: 88542 Exp. 03/2022; 88227 Exp. 12/2021; 88696 Exp. 05/2022; 89357 Exp. 08/2022

Distribution pattern: Nationwide.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification